|
Volumn 24, Issue 5, 2001, Pages 510-514
|
Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter
|
Author keywords
Dimethylarsinic acid; Dimethylbenz(a)anthracene; Inorganic arsenic; Reactive oxygen species; Skin tumor; Tumor promotion
|
Indexed keywords
ANTHRACENE DERIVATIVE;
ARSENIC;
CACODYLIC ACID;
CACODYLIC ACID PEROXY RADICAL;
DIMETHYBENZ[A]ANTHRACENE;
DRUG METABOLITE;
REACTIVE OXYGEN METABOLITE;
TUMOR PROMOTER;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CANCER GROWTH;
CONTROLLED STUDY;
DRUG METABOLISM;
EXPOSURE;
HUMAN;
KERATOSIS;
METABOLITE;
MOUSE;
NONHUMAN;
NUDE MOUSE;
PAPILLOMA;
SKIN CARCINOGENESIS;
SQUAMOUS CELL CARCINOMA;
TUMOR PROMOTION;
ULTRAVIOLET B RADIATION;
9,10-DIMETHYL-1,2-BENZANTHRACENE;
ADMINISTRATION, ORAL;
ANIMALS;
ARSENICALS;
COCARCINOGENESIS;
DEOXYGUANOSINE;
FEMALE;
MICE;
MICE, INBRED HRS;
MUTAGENS;
REACTIVE OXYGEN SPECIES;
SKIN NEOPLASMS;
ULTRAVIOLET RAYS;
|
EID: 0034986099
PISSN: 09186158
EISSN: None
Source Type: Journal
DOI: 10.1248/bpb.24.510 Document Type: Article |
Times cited : (74)
|
References (28)
|